Ticker Details
Kiniksa Pharmaceuticals, Ltd.
IPO Date:	May 21, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.62B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.47 | 2.63%
Avg Daily Range (30 D):	$0.82 | 1.77%
Avg Daily Range (90 D):	$0.78 | 1.80%

Institutional Daily Volume
Avg Daily Volume:	.3M
Avg Daily Volume (30 D):	.54M
Avg Daily Volume (90 D):	.47M

Trade Size
Avg Trade Size (Sh.):	69
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	61

Institutional Trades
Total Institutional Trades:	1,821
Avg Institutional Trade:	$1.78M
Avg Institutional Trade (30 D):	$1.77M
Avg Institutional Trade (90 D):	$2.13M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.79M
Avg Closing Trade (30 D):	$3.33M
Avg Closing Trade (90 D):	$2.63M
Avg Closing Volume:	82.8K

News

Oct 17, 2025 @ 12:00 PM Kiniksa Pharmaceuticals Announces U.S. Orphan Drug... Source: Kiniksa Pharmaceuticals International

Jun 5, 2025 @ 11:00 AM Kiniksa Pharmaceuticals Announces Trial Design of ... Source: N/A

May 29, 2025 @ 8:01 PM Kiniksa Pharmaceuticals to Present at Upcoming Inv... Source: N/A

Mar 14, 2025 @ 9:51 AM 3 No-Brainer Healthcare Stocks to Buy With $1,000 ... Source: Keith Speights

Feb 20, 2025 @ 9:01 PM Kiniksa Pharmaceuticals to Report Fourth Quarter a... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.8	$.19	$.8
Diluted EPS	$.75	$.18	$.75
Revenue	$677.56M	$202.13M	$677.56M
Gross Profit	$599.89M	$181.18M	$599.89M
Net Income / Loss	$59.01M	$14.2M	$59.01M
Operating Income / Loss	$77.22M	$19.77M	$77.22M
Cost of Revenue	$77.67M	$20.95M	$77.67M
Net Cash Flow	$-17.99M	$-9.26M	$-17.99M
PE Ratio	62.77